CRS was more severe in B-NHL patients treated with CD28-CD3ζ CAR T cells as compared to 4-1BB-CD3ζ CAR T cells, possibly due to the high immune response induced by CD28 stimulation (13). Here, CD28 is linked to congenital rubella syndrome.